Clinical Features and Long-Term Outcomes in Very Young Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries
Table 3
Pharmacological treatment at hospital discharge.
Pharmacological treatment
Hospital discharge
oCAD (n = 250)
MINOCA (n = 32)
Controls (n = 126)
value oCAD vs controls
value MINOCA vs controls
value oCAD vs MINOCA
P2Y12 Inhibitors
229 (94.7%)
13 (41.9%)
16 (13.4%)
<0.001
<0.001
<0.001
ASA
243 (100%)
25 (80.6%)
36 (30.3%)
<0.001
<0.001
<0.001
Anticoagulants
9 (3.8%)
0 (0.0%)
4 (3.4%)
0.853
0.305
0.277
Beta-blockers
200 (84.7%)
11 (35.5%)
23 (19.5%)
<0.001
0.059
<0.001
ACE inhibitors
117 (49.4%)
1 (3.2%)
12 (10.2%)
<0.001
0.223
<0.001
ARBs
10 (4.2%)
0 (0.0%)
10 (8.5%)
0.104
0.093
0.243
Calcium channel blockers
13 (5.5%)
10 (32.3%)
9 (7.6%)
0.436
<0.001
<0.001
Statins
221 (92.9%)
17 (54.8%)
18 (15.4%)
<0.001
<0.001
<0.001
Diuretics
17 (7.2%)
0 (0.0%)
8 (6.8%)
0.883
0.143
0.129
Antidiabetics
2 (0.9%)
1 (3.2%)
0 (0.0%)
0.315
0.050
0.239
Antiarrhythmics
5 (2.1%)
0 (0.0%)
3 (2.5%)
0.800
0.370
0.413
Data are given as number (percentage). oCAD, obstructive CAD. ASA, acetylsalicylic acid. ACE inhibitors; angiotensin-converting enzyme inhibitors. ARBs, angiotensin II receptor blocker.
